RadNet (RDNT) Competitors

Fresenius Medical Care (NYSE:FMS) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, community ranking, dividends, profitability, earnings, media sentiment, valuation and risk.

Does the MarketBeat Community favor FMS or RDNT?

Fresenius Medical Care received 67 more outperform votes than RadNet when rated by MarketBeat users. However, 66.29% of users gave RadNet an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
Fresenius Medical Care	Outperform Votes 423 54.72%	Underperform Votes 350 45.28%
RadNet	Outperform Votes 356 66.29%	Underperform Votes 181 33.71%

Which has stronger valuation & earnings, FMS or RDNT?

Fresenius Medical Care has higher revenue and earnings than RadNet. Fresenius Medical Care is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care	$19.34B	0.78	$540.07M	$0.99	25.88
RadNet	$1.83B	2.19	$3.04M	$0.03	1,779.33

Which has more volatility & risk, FMS or RDNT?

Fresenius Medical Care has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, RadNet has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500.

Do analysts recommend FMS or RDNT?

Fresenius Medical Care presently has a consensus target price of $25.30, indicating a potential downside of 1.25%. RadNet has a consensus target price of $69.75, indicating a potential upside of 30.67%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Fresenius Medical Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
RadNet	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.40

Is FMS or RDNT more profitable?

Fresenius Medical Care has a net margin of 3.43% compared to RadNet's net margin of -0.25%. Fresenius Medical Care's return on equity of 6.04% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care	3.43%	6.04%	2.69%
RadNet	-0.25%	4.29%	1.45%

Do institutionals and insiders hold more shares of FMS or RDNT?

8.4% of Fresenius Medical Care shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Does the media refer more to FMS or RDNT?

In the previous week, RadNet had 5 more articles in the media than Fresenius Medical Care. MarketBeat recorded 10 mentions for RadNet and 5 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.66 beat RadNet's score of 1.50 indicating that Fresenius Medical Care is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
RadNet	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

RadNet beats Fresenius Medical Care on 10 of the 19 factors compared between the two stocks.